Name | 3-(1-Piperazinyl)-1,2-Benzisothiazole |
---|---|
Synonyms |
3-(1-Piperazinyl)-1,2-benzothiazole
3-piperazin-1-yl-1,2-benzothiazole MFCD04117970 Lurasidone Impurity 13 |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 320.2±35.0 °C at 760 mmHg |
Melting Point | 91 °C |
Molecular Formula | C11H13N3S |
Molecular Weight | 219.306 |
Flash Point | 147.4±25.9 °C |
Exact Mass | 219.083023 |
PSA | 56.40000 |
LogP | 1.41 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.656 |
Storage condition | 2-8°C |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H315-H319 |
Precautionary Statements | P301 + P310-P305 + P351 + P338 |
Hazard Codes | Xi: Irritant; |
Risk Phrases | 25-36/38 |
Safety Phrases | 26-45 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | 3.0 |
HS Code | 2934200090 |
~71% 87691-87-0 |
Literature: MAPI PHARMA LTD.; MARON, Ehud; MIZHIRITSKII, Michael; TCHILIBON, Susanna; RUBNOV, Shai Patent: WO2013/14665 A1, 2013 ; Location in patent: Page/Page column 22; 23 ; |
~68% 87691-87-0 |
Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369 |
~% 87691-87-0 |
Literature: US5679827 A1, ; |
~% 87691-87-0 |
Literature: US4487773 A1, ; US 4487773 A |
~% 87691-87-0 |
Literature: Journal of Medicinal Chemistry, , vol. 29, # 3 p. 359 - 369 |
~% 87691-87-0 |
Literature: Journal of Medicinal Chemistry, , vol. 29, # 3 p. 359 - 369 |
~% 87691-87-0 |
Literature: Journal of Medicinal Chemistry, , vol. 29, # 3 p. 359 - 369 |
~% 87691-87-0 |
Literature: Journal of Medicinal Chemistry, , vol. 29, # 3 p. 359 - 369 |
Precursor 6 | |
---|---|
DownStream 8 | |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |